Trials / Completed
CompletedNCT02579954
Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pulmonary Arterial Hypertension is characterized by a progressive increase in pulmonary vascular resistance inducing shortness of breath and exercise intolerance. We aim to correlate cardiac function (evaluated at rest by right heart catheterism and RMN) to exercise capacity (evaluated by endurance time at 75% of maximal workout), in prevalent patients with pulmonary arterial hypertension, and their evolution at three and twelve months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Rehabilitation |
Timeline
- Start date
- 2015-08-06
- Primary completion
- 2022-12-05
- Completion
- 2024-01-24
- First posted
- 2015-10-20
- Last updated
- 2024-06-25
Locations
10 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02579954. Inclusion in this directory is not an endorsement.